StemCell Therapy

Mark Humayun University of Southern California Phase 1 Active, not recruiting 16 Tippi MacKenzie University of California, San Francisco Phase 1 Recruiting 10 Ralph Kern BrainStorm Cell Therapeutics Phase 3 Recruiting 200 Clive Svendsen Cedars-Sinai Medical Center Phase 1/2 Active, not recruiting 18 Crystal Mackall Stanford University Phase 1 Recruiting 57 Thomas Kipps University of California, San Diego Phase 1/2 Recruiting 156 Ed Conner Sangamo BioSciences, Inc. Phase 1/2 Recruiting 6 Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Launching N/A Thomas Kipps University of California, San Diego Phase 1 Active, not recruiting 29 Irving Weissman Stanford University Phase 1 Completed 88 Paul Finnegan Angiocrine Bioscience, Inc. Phase 1 Launching N/A Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Launching N/A Anthony Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 414 Christine Brown City of Hope, Beckman Research Institute Phase 1 Recruiting 92 Mark Chao Forty Seven Inc. Phase 1/2 Recruiting 112 Linda Marban Capricor, Inc Phase 2 Completed 25 Rachel Smith Capricor, Inc Phase 2 Active, not recruiting 134 Mehrdad Abedi University of California, Davis Phase 1/2 Recruiting 18 Geoff Symonds Calimmune, Inc. Phase 1/2 Completed 12 John Zaia City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 12 Vicki Wheelock University of California, Davis Phase 1/2 Completed 29 Everett Meyer Stanford University Phase 1 Launching N/A Jeffrey Lawson Humacyte, Inc. Phase 3 Active, not recruiting 355 Samuel Strober Stanford University Phase 1 Active, not recruiting 15 Jeffrey Lawson Humacyte, Inc. Phase 3 Recruiting 240 Scott Batty Medeor Therapeutics, Inc. Phase 3 Recruiting 75

See the original post here:
Funding Clinical Trials | California's Stem Cell Agency

This entry was posted on March 12, 2019 at 3:55 pm and is filed under Stem Cell kidney Failure. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |